MedTech Operations

A Strategic View: 12+1 Things You Should Do to Stay Ahead of the Competition
Dr. Roman Hipp | Dr. Till Giese
Jun 2018 | Strategy Paper | Anglais

MedTech Operations

A Strategic View: 12+1 Things You Should Do to Stay Ahead of the Competition

Disruptive business models, tech giants such as Google entering the market, and new innovative services are fundamentally changing the competitive environment within the MedTech industry. Established players are being forced to reconsider their way of doing business. Operations need to be adjusted in a way to prepare for the imminent revolution. While gross margin—a useful indicator of operational performance—is comparatively high within the MedTech business, production operations lack, for instance, the required dynamic to quickly respond to shifting market conditions. Since 2012, the leading MedTech companies have incrementally increased their gross margin by only 0.2 percent per year. Stagnation. 

The Porsche Consulting 12+1-step approach is designed to give MedTech firms guidance on how they can benefit from transformation.

100

top global MedTech companies were evaluated.

0.2%

was the increase of gross margin of leading MedTech companies since 2012. 

12+1

ideas for how managers can prepare their operations for disruption.

Management Summary
  • In order to stay ahead, MedTech incumbents need to comprehensively transform on all three levels: Strategy, technology and operations
  • The future operations structure of MedTech companies needs to be flexible, dynamic, efficient, IT-driven, compliant with respect to regulation, and consistent in incorporating complex global production networks. This is nothing less than an organizational masterpiece
  • A set of 12+1 steps helps MedTech business leaders to navigate their operations successfully through this time of great transformation

Read the whole strategy paper now

Contact

Consulting that works

You want to get in touch with our experts? Reach out to us.

Aperçus

Publications

La transformation globale du secteur de la santé

Retour d'expérience des CEOs dans l'industrie pharmaceutique et la medtech

Les nouvelles générations de médicaments

Relever les défis et transformer l'industrie pharmaceutique

La Qualité du Futur

Façonner le management de la qualité de demain

Filtrer

Industries

Practices